Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

  • Alwin Krämer
  • , Tilmann Bochtler
  • , Chantal Pauli
  • , Kai-Keen Shiu
  • , Natalie Cook
  • , Juliana Janoski de Menezes
  • , Roberto A Pazo-Cid
  • , Ferran Losa
  • , Debbie Gj Robbrecht
  • , Jiří Tomášek
  • , Cagatay Arslan
  • , Mustafa Özgüroğlu
  • , Michael Stahl
  • , Frédéric Bigot
  • , Sun Young Kim
  • , Yoichi Naito
  • , Antoine Italiano
  • , Nasséra Chalabi
  • , Gonzalo Durán-Pacheco
  • , Chantal Michaud
  • Jeremy Scarato, Marlene Thomas, Jeffrey S Ross, Holger Moch, Linda Mileshkin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry